AT MARKET ISSUANCE SALES AGREEMENTSpectrum Pharmaceuticals Inc • August 4th, 2017 • Pharmaceutical preparations • New York
Spectrum Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co. LLC (“HCW”), FBR Capital Markets & Co. (“FBR”) and MLV & Co. LLC (“MLV”, each of HCW, FBR and MLV, individually a “Distribution Agent” and collectively, the “Distribution Agents”) as follows:
